Needle-free administration of FeLV vaccines
AssigneeMerial Limited
InventorsTesfai Tseggai, Maria Camila Pardo, Alton Timothy Leard
Life of this patent
Estimating the term…
Abstract
The invention provides a novel method of vaccination of an animal of the felidae family against feline leukemia. The FeLV recombinant vaccine based on viral vector with the aid of a liquid jet needle-free injector can result in distribution of the vaccine essentially in the dermis and the hypodermis of the animal.
Claims18
A method of eliciting a safe and protective immune response against FeLV comprising administering a vaccine comprising an effective amount of a recombinant avipox vector containing and expressing an exogeneous nucleotide sequence encoding at least one FeLV immunogen and an acceptable vehicle or diluent, to a felidae with a liquid jet needle-free injector, wherein the vaccine comprises from about 104.5 to about 107.0 TCID50/dose.
A vaccination kit or set, comprising a liquid jet needle-free injector and at least one vaccine vial containing a vaccine consisting of a recombinant canarypox virus that contains and expresses in vivo a nucleic acid molecule encoding a FeLV antigen and a veterinarily acceptable carrier, operatively assembled to perform the administration of the vaccine to an animal of the felidae family and to elicit a safe and protective immune response against FeLV, wherein the vaccine comprises from about 104.5 to about 107.0 TCID50/dose.
Dependencies are inferred from the claim text.